Liquidia (LQDA) Free Cash Flow (2020 - 2026)
Liquidia's (LQDA) quarterly Free Cash Flow came in at $46.4 million in Q1 2026, up 231.44% year-on-year from $14.0 million in Q1 2025, and up 4.78% quarter-over-quarter from $44.3 million in Q4 2025.
Liquidia (LQDA) Free Cash Flow (2020 - 2026) Analysis & Trends
Liquidia's Free Cash Flow history runs 7 years deep, the most recent figure standing at $46.4 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 231.44% year-over-year to $46.4 million in Q1 2026; TTM through Mar 2026 was $43.8 million, a 142.38% increase from a year earlier, with the FY2025 full-year figure at -$37.9 million, up 59.48% from the prior year.
- Free Cash Flow improved to $46.4 million in Q1 2026 per LQDA's latest filing, from $44.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $46.4 million in Q1 2026 and bottomed at -$36.2 million in Q2 2025.
- The 5-year median for Free Cash Flow is -$10.7 million (2025), against an average of -$9.2 million.
- Across the five-year window, Free Cash Flow plunged 287.62% in 2024 and soared 355.09% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$5.1 million in 2022, then tumbled by 217.79% to -$16.2 million in 2023, then declined by 7.25% to -$17.4 million in 2024, then jumped by 355.09% to $44.3 million in 2025, then increased by 4.78% to $46.4 million in 2026.
- Per Business Quant, the three latest LQDA Free Cash Flow figures stand at $46.4 million (Q1 2026), $44.3 million (Q4 2025), and -$10.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 46.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.40 Mn |
| Mar 31, 2026 | 46.40 Mn |
| Dec 31, 2025 | 44.29 Mn |
| Dec 31, 2025 | 44.29 Mn |
| Sep 30, 2025 | -10.68 Mn |
| Sep 30, 2025 | -10.68 Mn |
| Jun 30, 2025 | -36.24 Mn |
| Jun 30, 2025 | -36.24 Mn |
| Mar 31, 2025 | -35.30 Mn |
| Mar 31, 2025 | -35.30 Mn |
| Dec 31, 2024 | -17.36 Mn |
| Dec 31, 2024 | -17.36 Mn |
| Sep 30, 2024 | -28.11 Mn |
| Sep 30, 2024 | -28.11 Mn |
| Jun 30, 2024 | -22.51 Mn |
| Jun 30, 2024 | -22.51 Mn |
| Mar 31, 2024 | -25.65 Mn |
| Mar 31, 2024 | -25.65 Mn |
| Dec 31, 2023 | -16.19 Mn |
| Dec 31, 2023 | -16.19 Mn |